SE7908701L - Difenyl-dibutylpiperazinkarboxamider - Google Patents

Difenyl-dibutylpiperazinkarboxamider

Info

Publication number
SE7908701L
SE7908701L SE7908701A SE7908701A SE7908701L SE 7908701 L SE7908701 L SE 7908701L SE 7908701 A SE7908701 A SE 7908701A SE 7908701 A SE7908701 A SE 7908701A SE 7908701 L SE7908701 L SE 7908701L
Authority
SE
Sweden
Prior art keywords
dibutylpiperazinkarboxamider
diphenyl
diphenyl dibutylpiperazinkarboxamider
Prior art date
Application number
SE7908701A
Other languages
Unknown language ( )
English (en)
Other versions
SE448730B (sv
Inventor
A K K Bjork
K G Olsson
A L Abramo
E G Christensson
Original Assignee
Ferrosan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan Ab filed Critical Ferrosan Ab
Publication of SE7908701L publication Critical patent/SE7908701L/sv
Publication of SE448730B publication Critical patent/SE448730B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L1/00—Enclosures; Chambers
    • B01L1/52—Transportable laboratories; Field kits
SE7908701A 1978-10-20 1979-10-19 Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand SE448730B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7810971 1978-10-20

Publications (2)

Publication Number Publication Date
SE7908701L true SE7908701L (sv) 1980-04-21
SE448730B SE448730B (sv) 1987-03-16

Family

ID=20336152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908701A SE448730B (sv) 1978-10-20 1979-10-19 Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand

Country Status (21)

Country Link
US (3) US4308387A (sv)
JP (1) JPS5557572A (sv)
AT (1) AT376666B (sv)
AU (1) AU529260B2 (sv)
BE (1) BE879528A (sv)
CA (1) CA1130807A (sv)
CH (1) CH643247A5 (sv)
DE (1) DE2941880A1 (sv)
DK (1) DK149057C (sv)
ES (1) ES485188A1 (sv)
FI (1) FI73986C (sv)
FR (1) FR2439187A1 (sv)
GB (1) GB2037745B (sv)
HK (1) HK57184A (sv)
IT (1) IT1207269B (sv)
LU (1) LU81807A1 (sv)
NL (2) NL190160C (sv)
NO (1) NO154582C (sv)
NZ (1) NZ191867A (sv)
SE (1) SE448730B (sv)
SG (1) SG7384G (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
WO1981003658A1 (en) * 1980-06-16 1981-12-24 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
ATE28327T1 (de) * 1981-12-02 1987-08-15 Ferrosan Ab 1-piperazinocarboxylate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
AT387572B (de) * 1983-05-20 1989-02-10 Ferrosan Ab Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
ES524680A0 (es) * 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
SE8304361D0 (sv) * 1983-08-10 1983-08-10 Ferrosan Ab Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
WO1990013539A1 (en) * 1989-04-28 1990-11-15 Meiji Seika Kaisha, Ltd. New n-substituted piperazine derivatives and drug for improving functional disorder of brain
FR2673182A1 (fr) * 1991-02-22 1992-08-28 Univ Caen Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
DE4307181C1 (de) * 1993-03-08 1994-11-10 Dresden Arzneimittel Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
DE29815747U1 (de) 1998-09-02 2000-01-05 Ramsauer Dieter Anschraubscharnier mit Raststellung
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB9923748D0 (en) * 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
GB0025354D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
GB0108594D0 (en) * 2001-04-05 2001-05-23 Glaxo Group Ltd Chemical compounds
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
US7332182B2 (en) 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7141250B2 (en) * 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US7157103B2 (en) 2001-08-06 2007-01-02 Euro-Celtique S.A. Pharmaceutical formulation containing irritant
US7482365B2 (en) * 2002-02-08 2009-01-27 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
JP4823673B2 (ja) * 2005-12-15 2011-11-24 タカラベルモント株式会社 ショックレス弁を接続した油圧回路
JP2010169206A (ja) * 2009-01-23 2010-08-05 Finesinter Co Ltd ノンリークショックレス電磁比例制御弁
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
PT2826467T (pt) 2010-12-22 2017-10-25 Purdue Pharma Lp Formas envolvidas de dosamento de libertação controlada resistentes à adulteração
CA2822769C (en) 2010-12-23 2016-10-04 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
SG11201506064UA (en) 2013-02-05 2015-08-28 Purdue Pharma Lp Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137318C (sv) * 1964-06-09
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative

Also Published As

Publication number Publication date
JPS6326756B2 (sv) 1988-05-31
NO154582C (no) 1986-11-05
NL190160C (nl) 1993-11-16
NL940004I1 (nl) 1994-05-02
DK149057B (da) 1986-01-06
SE448730B (sv) 1987-03-16
ATA683479A (de) 1984-05-15
AU529260B2 (en) 1983-06-02
FI73986C (sv) 1987-12-10
CH643247A5 (de) 1984-05-30
ES485188A1 (es) 1980-05-16
NO793315L (no) 1980-04-22
GB2037745A (en) 1980-07-16
FI793238A (fi) 1980-04-21
DE2941880A1 (de) 1980-04-30
BE879528A (fr) 1980-04-21
DK149057C (da) 1986-06-02
AT376666B (de) 1984-12-27
FI73986B (fi) 1987-08-31
DK442779A (da) 1980-04-21
IT1207269B (it) 1989-05-17
AU5198479A (en) 1980-06-19
FR2439187B1 (sv) 1983-03-18
DE2941880C2 (sv) 1989-04-20
US4308387A (en) 1981-12-29
NL190160B (nl) 1993-06-16
NO154582B (no) 1986-07-28
SG7384G (en) 1985-02-08
NL7907741A (nl) 1980-04-22
GB2037745B (en) 1982-11-24
US4385057A (en) 1983-05-24
FR2439187A1 (fr) 1980-05-16
NZ191867A (en) 1983-06-14
CA1130807A (en) 1982-08-31
HK57184A (en) 1984-08-03
LU81807A1 (de) 1980-01-25
US4447433A (en) 1984-05-08
IT7926603A0 (it) 1979-10-18
JPS5557572A (en) 1980-04-28

Similar Documents

Publication Publication Date Title
SE7908701L (sv) Difenyl-dibutylpiperazinkarboxamider
AT370950B (de) Hoeschenwindel
ATA279A (de) Akupunkturgeraet
BE872071A (fr) Afdichtorgaan
BR7902161A (pt) Estojo
AT365922B (de) Netzbett
BE879521A (fr) Schroefkap met borgrand
FI791756A (fi) Saekerhetsanordning foer personbefordringsanlaeggningar
AT374352B (de) Sportschuh
FI792367A (fi) Raffineringsugn foer icke-jaernmetaller
BE873461A (fr) Kleerhanger
TR20165A (tr) Feniluereler
BE875202A (fr) Buisdeel met beweegbare stootrand
AR218561A1 (es) Copoliester p-oxibenzoilico
ATA872778A (de) Uhrband
BE880106A (fr) Vermogengestuurd inbouwelement met warmtewisselaar
BE876178A (fr) Snijkop met verstelbare zuigmond
SE7904740L (sv) Cykellas
ATA26879A (de) B-ettbank
AT368010B (de) Rollskier
BE871213R (fr) Arylmalonamido-1-oxadethiacephalosporines
AT355471B (de) Schipresse
AR224881A1 (es) 2-hidroxifenilbenzotiazoles
ATA510278A (de) Griffel
AT361359B (de) Skistock

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7908701-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7908701-1

Format of ref document f/p: F